Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...
Engaging Patients, Oncologists, and Primary Care Clinicians in the Care of Cancer Survivors: A Coordinated Care Model With System-Level Technology to Move the Outcomes Needle If a pilot was attempting ...
The US-based START Center for Cancer Research (START) and OneOncology have collaborated to introduce three early-phase trial sites in the US. The partners will launch START trial sites at the Los ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results